These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 685877)

  • 21. Protein metabolism in patients with chronic renal failure: role of uremia and dialysis.
    Lim VS; Kopple JD
    Kidney Int; 2000 Jul; 58(1):1-10. PubMed ID: 10886544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of carnitine in modulating acute-phase protein synthesis in hemodialysis patients.
    Bellinghieri G; Santoro D; Calvani M; Savica V
    J Ren Nutr; 2005 Jan; 15(1):13-7. PubMed ID: 15648000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein in the diets of dialyzed and non-dialyzed uremic patients. Study with nitrogen-labeled urea.
    Smith EB; Hill PA
    J Am Diet Assoc; 1972 May; 60(5):389-93. PubMed ID: 5018368
    [No Abstract]   [Full Text] [Related]  

  • 24. Hyperleptinemia in uremic patients undergoing conservative management, peritoneal dialysis, and hemodialysis: A comparative analysis.
    Fontán MP; Rodríguez-Carmona A; Cordido F; García-Buela J
    Am J Kidney Dis; 1999 Nov; 34(5):824-31. PubMed ID: 10561137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum uremic toxins from patients with chronic renal failure displace the binding of L-tryptophan to human serum albumin.
    Mingrone G; De Smet R; Greco AV; Bertuzzi A; Gandolfi A; Ringoir S; Vanholder R
    Clin Chim Acta; 1997 Apr; 260(1):27-34. PubMed ID: 9101098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Albumin Turnover in Peritoneal and Hemodialysis.
    Rippe B; Öberg CM
    Semin Dial; 2016 Nov; 29(6):458-462. PubMed ID: 27525385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary Intake of Proteins and Calories Is Inversely Associated With The Oxidation State of Plasma Thiols in End-Stage Renal Disease Patients.
    Fanti P; Giustarini D; Rossi R; Cunningham SE; Folli F; Khazim K; Cornell J; Matteucci E; Bansal S
    J Ren Nutr; 2015 Nov; 25(6):494-503. PubMed ID: 26235932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative contributions of body iron status and uremia severity to anemia in patients with advanced chronic renal failure.
    Ifudu O; Dawood M; Friedman EA
    Nephron; 1997; 77(3):315-8. PubMed ID: 9375826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertriglyceridemia in uremia and the use of triglyceride turnover to define pathogenesis.
    Cattran DC; Steiner G; Fenton SS; Wilson DR
    Trans Am Soc Artif Intern Organs; 1974; 20A():148-52. PubMed ID: 4450333
    [No Abstract]   [Full Text] [Related]  

  • 30. Geographic factors and plasma selenium in uremia and dialysis.
    Bonomini M; Forster S; Manfrini V; De Risio F; Steiner M; Vidovich MI; Klinkmann H; Ivanovich P; Albertazzi A
    Nephron; 1996; 72(2):197-204. PubMed ID: 8684527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocrinology and metabolism in uremia and dialysis: a clinical review.
    Feldman HA; Singer I
    Medicine (Baltimore); 1975 Sep; 54(5):345-76. PubMed ID: 808679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.
    Sherwin RS; Bastl C; Finkelstein FO; Fisher M; Black H; Hendler R; Felig P
    J Clin Invest; 1976 Mar; 57(3):722-31. PubMed ID: 1249205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Albumin loss under the use of the high-performance membrane.
    Tsuchida K; Minakuchi J
    Contrib Nephrol; 2011; 173():76-83. PubMed ID: 21865779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary management in chronic hemodialysis.
    Pendras JP
    Am J Clin Nutr; 1968 Jun; 21(6):638-41. PubMed ID: 5666642
    [No Abstract]   [Full Text] [Related]  

  • 35. Dialyzable uremic solutes contribute to enhanced oxidation of serum albumin in regular hemodialysis patients.
    Terawaki H; Nakayama K; Matsuyama Y; Nakayama M; Sato T; Hosoya T; Era S; Ito S
    Blood Purif; 2007; 25(3):274-9. PubMed ID: 17460395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients.
    Tsubakihara Y; Takabatake Y; Oka K; Shoji T; Togawa M; Okada N; Takahito I; Imai E
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S38-41. PubMed ID: 12612950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.
    de Mutsert R; Grootendorst DC; Indemans F; Boeschoten EW; Krediet RT; Dekker FW;
    J Ren Nutr; 2009 Mar; 19(2):127-35. PubMed ID: 19218039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitrogen balance during intermittent dialysis therapy of uremia.
    Borah MF; Schoenfeld PY; Gotch FA; Sargent JA; Wolfsen M; Humphreys MH
    Kidney Int; 1978 Nov; 14(5):491-500. PubMed ID: 750694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Observation of the course of 4-year ambulatory peritoneal dialysis in the treatment of chronic uremia].
    Korten G; Kröger E
    Z Urol Nephrol; 1981 Apr; 74(4):305-10. PubMed ID: 7269816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced in vitro binding of tryptophan by plasma in uremia.
    de Torrente A; Glazer GB; Gulyassy P
    Kidney Int; 1974 Oct; 6(4):222-9. PubMed ID: 4427418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.